Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 52 out of 100. Caregiving

Topic: Risk, prevention and care in population studies

Plain-language summary

Objectives To identify the components of advance care planning (ACP) programs implemented in nursing homes, evaluate the range of associated end-of-life (EoL) outcomes for individuals with dementia and their caregivers, and assess their overall effectiveness. Design Systematic review and meta-analysis of randomized controlled trials (RCTs) and observational studies. Setting and participants Individuals with dementia in nursing homes, their caregivers, and staff members. Methods We searched PubMed, Embase, Cochrane Library, and ClinicalTrials.gov from inception to December 31, 2024. Studies were eligible if they evaluated ACP interventions delivered in nursing home settings and reported EoL outcomes for individuals with dementia and/or their caregivers. Risk of bias was assessed using the Cochrane ROB 2.0 tool for RCTs and the ROBINS-I tool for observational studies. Certainty of evidence was evaluated using the GRADE framework. Results Ten studies, all conducted in the United States, the United Kingdom, Belgium, France, and Finland, were included; no studies were identified from non-Western countries. Most studies had a moderate to high risk of bias. Owing to heterogeneity in outcome definitions and measurements, the results from the 5 RCTs were not meta-analyzed. Three observational studies assessing the place of death were pooled (n = 1136), showing no significant association between ACP and nursing home death [odds ratio (OR), 1.62; 95% CI, 0.72-3.66; I 2 = 69%]. Two studies (n = 453) found that ACP significantly increased documentation of do-not-resuscitate (DNR) directives (OR, 14.12; 95% CI, 3.95-50.47; I 2 = 0%). Certainty of evidence was very low for both nursing home death and DNR documentation. Conclusions and implications Although ACP programs in nursing homes may increase DNR directives, evidence of other EoL outcomes remains limited and inconsistent. No included studies were conducted in non-Western settings, highlighting the need for culturally sensitive research and standardized outcome reporting in related research.

What this study adds

Evidence grade: Early

This is a pooled review. This review of advance care planning programs in nursing homes found the studies were too different to combine, and pooling three studies on place of death showed no significant link. Reported effect size: DNR documentation OR 14.12 (95% CI 3.95-50.47); nursing home death OR 1.62 (95% CI 0.72-3.66, not significant).

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Lin, Y. J., Chen, Y. J., Ling, D. I., Fang, JR., Wu, J. Y., & Lo, Y. T. (2025). Effectiveness of Advance Care Planning for End-of-Life Outcomes in Nursing Home Residents With Dementia: A Systematic Review and Meta-Analysis. Journal of the American Medical Directors Association. https://doi.org/10.1016/j.jamda.2025.105974

Vancouver

Lin YJ, Chen YJ, Ling DI, Fang JR, Wu JY, Lo YT. Effectiveness of Advance Care Planning for End-of-Life Outcomes in Nursing Home Residents With Dementia: A Systematic Review and Meta-Analysis. Journal of the American Medical Directors Association. 2025. doi:10.1016/j.jamda.2025.105974. PMID: 41198038.

BibTeX

@article{lin2025-41198038,
  author  = {Lin, Y. J. and Chen, Y. J. and Ling, D. I. and Fang, JR. and Wu, J. Y. and Lo, Y. T.},
  title   = {{Effectiveness of Advance Care Planning for End-of-Life Outcomes in Nursing Home Residents With Dementia: A Systematic Review and Meta-Analysis}},
  journal = {Journal of the American Medical Directors Association},
  year    = {2025},
  doi     = {10.1016/j.jamda.2025.105974},
  pmid    = {41198038},
  url     = {https://doi.org/10.1016/j.jamda.2025.105974}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This review of advance care planning programs in nursing homes found the studies were too different to combine, and pooling three studies on place of death showed no significant link. It offers no evidence that advance care planning changes the course of dementia.

Study details

Limitations

Few and heterogeneous studies; high risk of bias; only Western settings; outcomes such as comfort or family satisfaction rarely measured consistently.

How this study scored 52/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 12 of 12; Strength of evidence 2 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 3 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 2 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 1 of 4; Institution's track record 1 of 3; Multicenter collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read left out, no data. 51 of the 98 points it could be judged on, which is 52 of 100. Total 52 of 100.51 of the 98 points we could judge = 52 of 100

Published in a peer-reviewed journal, and it is a meta-analysis pooling many studies. Scored zero for sample size and studied in people because the record does not state it. We have no data on free to read, so that was left out: it earned 51 of the 98 points we could judge it on, which is 52 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Journal of the American Medical Directors Association)
Journal's citation record 2 / 4 Journal of the American Medical Directors Association: journal h-index 172 (OpenAlex, 2026-10-29)
Study design 12 / 12 A meta-analysis pooling many studies
Strength of evidence 2 / 5 Rated “early” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 A review of other studies — randomization is not credited here
Times cited 1 / 7 Cited 4 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.3 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 1.2× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 4 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Yu‐Tai Lo: h-index 9 (OpenAlex, whole career)
Institution's track record 1 / 3 Weill Cornell Medicine: institution h-index 1,163 (OpenAlex)
Multicenter collaboration 2 / 3 OpenAlex lists 4 institution(s) in 2 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41198038)
Free to read — / 2 Access not recorded — left out of this score
Points 51 / 98 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 51 of the 98 points we could judge it on is 52 out of 100.
Total 52 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription Unpaywall, Europe PMC and OpenAlex found no free copy of the full text (checked 10 Oct 2026), so the publisher may charge for it. The PubMed abstract is free.

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Caregiving from nearby years

Also tagged “nursing”

995 studies in the library carry the topic tag “nursing”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 995 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Caregiving

See all studies in Caregiving →